WHAT’S NEW IN THE MANAGEMENT OF STROKE? - QUOI DE NEUF DANS LA GESTION DE L'AVC ? (TC-104)

Saturday, October 28, 2023

10:15 – 10:45 EST

Location: Palais, 519AB

Presenter(s)

Mike Sharma, MD, MSc, FRCPC

Associate Professor and Neurologist
McMaster University Population Health Researcch Institute

Disclosure(s):

Mike Sharma, MD, MSc, FRCPC: Alexion: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AstraZeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boes/Janssen: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing); Janssen: Consultant/Advisory Board (Ongoing); Javelin Medical: Consultant/Advisory Board (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

dscuss the standards for antithrombotic choice in stroke prevention;
select management options for patients with PFO; and
develop an approach to stroke recurrence on OAC.

In this session attendees will be provided with an update on decision-making in three areas of stroke management that may appear perplexing. Antithrombotic choices in secondary prevention and the approach to management of patients with PFO will be reviewed along with the approach to the occurrence of stroke in patients with AF on anticoagulants.